• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients.

作者信息

Andrade-Sierra Jorge, Contreras Ana M, Monteon Francisco J, Celis Alfredo, Gutierrez Rodolfo, Montañez Jose L, Ruelas Sara, Baid-Agrawal Seema, Chung Raymond T

机构信息

Department of Nephrology and Transplant Unit, Specialties Hospital, West National Medical Center, Mexican Institute of Social Security, Guadalajara, Jalisco, México.

出版信息

Arch Med Res. 2006 Nov;37(8):961-6. doi: 10.1016/j.arcmed.2006.05.004.

DOI:10.1016/j.arcmed.2006.05.004
PMID:17045111
Abstract

BACKGROUND

Many risk factors are associated with the development of posttransplant diabetes mellitus (PTDM), which has adverse effects on graft and patient survival. We report the incidence and risk factors associated with the development of PTDM in Mexican kidney recipients.

METHODS

In a retrospective cohort study, we included kidney transplants performed between January 1, 1994 and December 31, 2000; all patients were followed up for at least 1 year posttransplantation. PTDM was defined as fasting blood glucose >126 mg/dL on at least two occasions. Statistical analysis included estimation of crude relative risk (RR) with 95% confidence intervals (CI). Adjusted RR and 95% CI by logistic regression were used.

RESULTS

We studied 522 kidney recipients. Fifty three (10.1%) cases of PTDM were identified in this cohort. Cumulative dosage of prednisone (PDN) >13 g (RR 7.6, 95% CI 1.5-16.3 p <0.0001) and the presence of >or=1 acute rejection episodes (RR 3.7, 95% CI 1.2-11.6 p <0.001 were independent risk factors associated with the development of PTDM. Obesity (RR 2.6, 95% CI 0.8-8.7, p = 0.083) and age range of 40-49 years (RR 2.0; 95% CI 0.6-7.2, p = 0.093) were identified as marginal risk factors.

CONCLUSIONS

The incidence of PTDM in kidney recipients was 10.1% in our population. Cumulative PDN dosage and presence of >or=1 acute rejection episodes were independent risk factors for the development of PTDM. These results are consistent with prior studies of the diabetogenic effect of the PDN. The relationship between acute rejection and PTDM deserves further investigation in order to learn more about the role that inflammatory mechanisms may play in this association.

摘要

相似文献

1
Risk factors and incidence of posttransplant diabetes mellitus in Mexican kidney recipients.
Arch Med Res. 2006 Nov;37(8):961-6. doi: 10.1016/j.arcmed.2006.05.004.
2
Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.他克莫司的使用与移植后糖尿病的发生:一项巴西单中心观察性研究。
Transplant Proc. 2010 Mar;42(2):475-8. doi: 10.1016/j.transproceed.2010.02.021.
3
Risk factors for development of posttransplant diabetes mellitus in renal transplant recipients.肾移植受者发生移植后糖尿病的危险因素。
Transplant Proc. 2006 Mar;38(2):529-32. doi: 10.1016/j.transproceed.2005.12.066.
4
Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients.肾移植受者移植后糖尿病的危险因素及发病率
Transplant Proc. 2004 Sep;36(7):2139-40. doi: 10.1016/j.transproceed.2004.08.118.
5
Posttransplant diabetes mellitus: incidence and risk factors.移植后糖尿病:发病率及危险因素
Transplant Proc. 2008 Apr;40(3):764-6. doi: 10.1016/j.transproceed.2008.03.018.
6
Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.肾移植后新发糖尿病对常染色体显性多囊肾病患者移植肾功能的影响。
Ann Acad Med Stetin. 2008;54(1):41-8.
7
Risk factors and outcomes associated with posttransplant diabetes mellitus in kidney transplant recipients.肾移植受者移植后糖尿病的危险因素及预后
Transplant Proc. 2010 Jun;42(5):1685-9. doi: 10.1016/j.transproceed.2009.12.062.
8
Posttransplant diabetes mellitus: incidence and risk factors.移植后糖尿病:发病率及危险因素
Transplant Proc. 2009 Sep;41(7):2811-3. doi: 10.1016/j.transproceed.2009.07.043.
9
Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.肾移植受者早期移植后糖尿病的临床特征、他克莫司药代动力学及相关基因多态性的发生率和危险因素
Transplant Proc. 2005 May;37(4):1865-7. doi: 10.1016/j.transproceed.2005.02.086.
10
Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus.服用他克莫司的肾移植受者代谢综合征和移植后糖尿病的发病率及危险因素。
Transplant Proc. 2010 Oct;42(8):2902-4. doi: 10.1016/j.transproceed.2010.08.005.

引用本文的文献

1
Prevalence of new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis.肾移植后新发糖尿病的患病率:系统评价和荟萃分析。
Acta Diabetol. 2024 Jul;61(7):809-829. doi: 10.1007/s00592-024-02253-w. Epub 2024 Mar 20.
2
Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.马来西亚主要移植中心新诊断糖尿病(NODAT)的临床和遗传危险因素。
BMC Nephrol. 2020 Sep 7;21(1):388. doi: 10.1186/s12882-020-02052-9.
3
Risk factors for new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis.
肾移植后新发糖尿病的危险因素:系统评价和荟萃分析。
J Diabetes Investig. 2021 Jan;12(1):109-122. doi: 10.1111/jdi.13317. Epub 2020 Jul 12.
4
Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.全身糖皮质激素治疗:代谢和心血管不良事件综述。
Drugs. 2014 Oct;74(15):1731-45. doi: 10.1007/s40265-014-0282-9.